Vitamin markets: Some B3 suppliers stopped offering and folic acid price rises
Vitamin A and E have become rather static. Suppliers have no intention at all to reduce prices and buyers are not in the market to buy new volume. Therefore, prices for the balance is stable but at a high level. Learn more in this week’s feed additives snapshot (week 48).
Vitamin D3 remains firm and suppliers in China are very keen to increase the price further. Availability is tight in most regions. Prices have been stable to firm last week and no significant change expected there. Some vitamin B3 suppliers have stopped offering in an attempt to increase the price. No reaction from the market, but it is still early stages and the coming weeks will give more direction. For now the price remained stable. Folic acid suppliers have significantly increased their price. In China and the USA that has led to higher transaction prices, but in other regions no impact seen yet. Folic acid has been static for a long time, maybe this will change the trend, time will tell. Other vitamins show little change compared to previous weeks.
In partnership with Feed Additive Prices
Vitamin E 50%
No specific news and/or updates are seen, so far, this week. There is an ongoing trend of buyers that continue to wait and see and suppliers that have a strong desire to maintain current market prices. This has so far resulted in mostly stable prices in all regions, although stable at a high level. No short-term changes are expected to these dynamics. Right now the market is relatively quiet and contracted for Q4 and a good portion of Q1.
Vitamin A 1000
Also for vitamin A1000, no specific news or updates are seen. Prices are mostly stable but at a high price level. Manufacturers and suppliers are keen to hold up these high prices. Buyers have a strong wait-and-see attitude and can still carry on with their current contracts into early Q1. New suppliers from China are becoming more visible now and new capacity can be expected in 2025. Buyers have already secured most of their Q4 and some Q1 needs.
Vitamin D3 500
The general tone is still tight, although no significantly higher prices are being paid. Some price increases are seen here and there. Recently, several manufacturers announced significant price increases. Most buyers are contracted ahead but will have to return to the market in late Q4 again if they do not cover anything right now for Q1. Q4 is mostly contracted and a small portion of Q1 as well. But in general, the market is in a wait-and-see mode, despite the currently firmer market.
Vitamin B2 80%
Prices in Europe remain firmer compared to earlier this year, as there are no Chinese sources available, and Western sources indicate to have limited material available. By now most of Q4 has been contracted and a good portion of Q1 as well.
D-Calpan
Recently, several suppliers tried to increase prices, but so far they have not managed to get the market moving. Prices remain stable at a relatively low level and that goes for all regions. As there is an oversupply situation for this product, no signs of change are expected in the short term. Q4 is mostly contracted and a good portion of Q1 is as well.
Vitamin B3
Several suppliers have stopped offering. The market has not really reacted so far and is still relatively quiet. Buyers have secured their Q4 and partially Q1 needs and after that, the market has gone quiet. Contract execution and availability seem to be okay.
Biotin
No signs of any sort of change in the biotin market are seen or reported. Very static market at the moment. New additional production capacity in China has recently been announced for 2025. Q4 and a good portion of Q1 are contracted.
Vitamin C 35% mono
After some activity in the past few weeks and some firmer pricing, the market has become quiet again. Suppliers continue to insist on higher prices, therefore the current price level seems to be sticking. Q4 and a portion of Q1 have been contracted.
